Literature DB >> 11033396

Choroidal neovascularization in myopic eyes after photorefractive keratectomy.

J M Ruiz-Moreno1, A Artola, M J Ayala, P Claramonte, J L Alió.   

Abstract

PURPOSE: To evaluate the incidence, characteristics, and results of treatment of choroidal neovascularization (CNV) in myopic eyes corrected by photorefractive keratectomy (PRK).
SETTING: University Miguel Hernández, Instituto Oftalmológico de Alicante, Alicante, Spain.
METHODS: This study was of the incidence of CNV in 5936 consecutive eyes that had PRK for the correction of myopia. Mean follow-up was 38.5 months +/- 17.4 (SD).
RESULTS: Extrafoveal CNV developed in the right eye of a 44-year-old woman 26 months after PRK for the correction of -12.00 diopters (D) of myopia. The follow-up after PRK was 38 months. Best corrected visual acuity (BCVA) before PRK was 20/40 (spherical equivalent [SE] -12.00 D). After PRK, BCVA was 20/32 SE -1.75 D). The CNV was treated by direct argon-green laser photocoagulation and did not recur in the subsequent 12 months). After CNV treatment, BCVA was 20/32 (SE -2.25 D).
CONCLUSION: The incidence of CNV after PRK for myopia was low. Choroidal neovascularization is a possible complication in myopic eyes, and the risk exists before PRK. After PRK, the risk of CNV in myopic patients did not increase.

Entities:  

Mesh:

Year:  2000        PMID: 11033396     DOI: 10.1016/s0886-3350(00)00479-x

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Retinal detachment after laser in situ keratomileusis.

Authors:  Saba Al-Rashaed; Ali M Al-Halafi
Journal:  Middle East Afr J Ophthalmol       Date:  2011-07

2.  Choroidal neovascularization following photorefractive keratectomy.

Authors:  Hamidreza Torabi; Seyed-Hashem Daryabari
Journal:  J Curr Ophthalmol       Date:  2016-09-09

3.  Macular hole after laser in situ keratomileusis in a 26-year-old patient.

Authors:  Guzel Bikbova; Toshiyuki Oshitari; Madoka Sakurai; Takayuki Baba; Shuichi Yamamoto
Journal:  Case Rep Ophthalmol Med       Date:  2013-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.